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Abstract
Air pollution continues to be an environmental public health issue in Scot-
land, despite marked improvements in concentrations in recent decades. The
Scottish Government is committed to tackling this problem, having published
the Cleaner Air For Scotland (CAFS) strategy in 2015 and committing to
introduce Low Emission Zones (LEZs) in the four major cities (Aberdeen,
Dundee, Edinburgh and Glasgow) between 2018 and 2020. However, there
is no epidemiological evidence quantifying the current health impact of long-
term exposure to air pollution in Scotland, a gap this paper fills. Addition-
ally, we estimate the health benefits of reducing concentrations in city centres
where most LEZs are located. We focus on cardio-respiratory disease and
total non-accidental mortality outcomes, linking them to concentrations of
both particulate (PM10 and PM2.5) and gaseous (NO2 and NOx) pollutants.
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Our two main findings are that: (i) all 4 pollutants exhibit associations with
respiratory disease but not cardiovascular disease; and (ii) reducing pollution
concentrations in city centres with low resident populations only provides a
small health benefit.
Keywords: Air pollution, Cardio-respiratory disease, Epidemiological
modelling, Spatially-varying health impacts.
1. Introduction1
Air pollution is the biggest environmental risk to health across the world,2
with the World Health Organisation (WHO) estimating that 3 million deaths3
are attributable to it each year (World Health Organisation, 2016). Pollution4
concentrations around the world are above safe levels, with an estimated 90%5
of the population living in areas where pollutants exceed WHO guideline6
levels (also World Health Organisation, 2016). The true impact on health7
is difficult to measure directly, and estimates vary with wide uncertainty8
intervals. The United Kingdom (UK) Royal College of Physicians estimated9
that up to 40,000 deaths could be attributable to air pollution each year10
(Royal College of Physicians, 2016).11
The focus of this study is Scotland, UK, where pollution concentra-12
tions are now comparatively low, although there are 39 declared Air Qual-13
ity Management Areas (AQMA, http://www.scottishairquality.co.uk/14
laqm/aqma), which either breach or are likely to breach legal pollution limits15
set by the European Union (EU, European Parliament, 2008). The majority16
of these breaches are for nitrogen dioxide (NO2, 27 areas) and / or coarse17
particulate matter (PM10, 24 areas), with only one for sulphur dioxide (SO2).18
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Figure 1: Boundary of Glasgow City Councils Air Quality Management Area, which is
the location for the proposed LEZ.
The Scottish Government published the Cleaner Air For Scotland (CAFS)19
strategy (http://www.gov.scot/Resource/0048/00488493.pdf) in 2015,20
which proposes interventions directed particularly at reducing traffic related21
pollution. One such intervention is a Low Emission Zone (LEZ), where ve-22
hicles that do not meet specified emission standards are banned from, or23
attract fines for, entering the zone. The first LEZ in Scotland was intro-24
duced in the city of Glasgow at the end of 2018 (https://news.gov.scot/25
news/first-low-emission-zone-for-glasgow), with a phased implemen-26
tation over 5 years starting with buses that do not meet the EURO 6 emission27
standard. The other 3 main cities (Aberdeen, Dundee and Edinburgh) are28
mandated by the Scottish Government to follow suit by the end of 2020.29
The location for the Glasgow LEZ is the city centre (see Figure 1), bounded30
by the M8 motorway (west and north), river Clyde (south) and High street31
(east).32
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The city centre has been specified for the LEZ because it was identified as33
the area most likely to exceed EU limit values for NO2 through the assessment34
of air quality data. For example, despite the continual improvements in mea-35
sured NO2, the Glasgow Kerbside monitoring station (in the city centre) con-36
tinually exceeds the EU limit of 40µgm−3 for annual mean NO2, with many of37
the passive diffusion tube sites within the city centre AQMA also continuing38
to exceed this limit (see http://www.scottishairquality.co.uk/assets/39
documents//Glasgow_LAQM_Annual_Progress_Report_2017.pdf).40
The boundaries for the Glasgow LEZ are based on achieving regulatory41
compliance, and are not specifically designed to take account of the likely42
public health impact of reducing pollution in that locality. The beneficial43
health impact of an LEZ will depend on the size, demographics and under-44
lying health of the population who spend time in the LEZ, as well as on the45
scale of reduction in pollution concentrations that it achieves. Thus while the46
city centre has the highest pollution concentrations within the city, it also47
has a very low resident population and thus may have a limited impact on48
the majority of Glasgow’s population This preceding argument however does49
not account for people who travel into the city centre for work or pleasure50
for large periods of time, which illustrates the complexity of comprehensively51
evaluating the health impact of an LEZ.52
Our aims for this paper are two-fold, with the first being to provide up-53
to-date policy relevant evidence about the impact of long-term exposure to54
coarse and fine particulate matter (PM10 and PM2.5) and oxides of nitrogen55
(NO2 and NOx) on a range of health outcomes to address the gap in the56
evidence base about the health impacts of current levels of air pollution57
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concentrations in Scotland. Existing studies include Lee et al. (2009); Lee58
(2012); Willocks et al. (2012); Dibben and Clemens (2015) and Huang et al.59
(2015), but are based on relatively old data up to 2011. Our second aim is60
to use our modelling results to estimate the spatially-varying health benefits61
of reducing air pollution concentrations in Scotland’s cities, specifically in62
city centres where LEZs are most likely to be located. The data and study63
region are presented in Section 2, while the proposed statistical methodology64
is outlined in Section 3. The results of the study are presented in Section 4,65
while a note of caution about comparing the results here to other studies is66
presented in Section 5. Finally, the key conclusions are presented in Section67
6.68
2. Data and study design69
The study is based in mainland Scotland for the two-year period 2015-70
2016, and the study region has been spatially partitioned into K = 125271
Intermediate Zones (IZ) that have an average population of around 4,000.72
The health effects associated with air pollution are estimated from the spatial73
contrasts in population-level disease incidence and air pollution concentra-74
tions across the study region, after adjusting for population demographics75
and socio-economic deprivation.76
2.1. Disease data77
The data are counts of the numbers of disease events from the popula-78
tions living in each IZ in the two-year study period, and we consider the79
following 5 outcomes: respiratory hospitalisations and mortalities, cardio-80
vascular hospitalisations and mortalities, and total non-accidental mortali-81
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ties. All of these outcomes have been associated with air pollution in the82
existing literature (see Schwartz et al., 2001; Brook et al., 2004 and Lee83
et al., 2009), and cardiovascular and respiratory disease are two of Scotland’s84
leading causes of deaths (see http://www.gov.scot/Topics/Statistics/85
Browse/Health/TrendMortalityRates). These data are summarised in Ta-86
ble 1, which presents percentiles of the spatial distribution of each outcome87
across the 1252 IZs.88
The area level disease counts depend on the size and age-sex structure of89
the population at risk within each areal unit (IZ), which is accounted for by90
computing the expected number of disease events in each IZ using indirect91
standardisation. Specifically, the population living within each IZ is split92
into strata based on 5-year age bands and sex, and the number of people in93
each strata is multiplied by national strata specific disease rates, which are94
then summed over strata to compute the expected count. Letting (Yk, ek)95
respectively denote the observed and expected numbers of disease events96
in the kth IZ, an exploratory measure of disease risk is the Standardised97
Morbidity / Mortality Ratio (SMR), which is computed as SMRk = Yk/ek.98
An SMR of one corresponds to an average risk area, while an SMR of 1.299
corresponds to a 20% increased risk of disease compared to the Scottish100
average. The spatial pattern in the SMR for respiratory hospitalisations is101
displayed in panel A of Figure 2, which shows that the majority of the IZs are102
in the heavily populated central belt of Scotland containing the two largest103
cities Glasgow and Edinburgh. A large number of the high SMRs (dark104
colours) are in the city of Glasgow, which is known to exhibit some of the105
worst health in the United Kingdom (Walsh et al., 2017). The SMRs for the106
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Table 1: Summary of the spatial distribution of the disease and pollution data across the
1252 Intermediate Zones.
Variable
Percentiles of the distribution
0% 25% 50% 75% 100%
Disease incidents (total counts)
Cardiovascular hospitalisation 26 101 131 166 354
Cardiovascular mortality 2 16 22 30 90
Respiratory hospitalisation 34 108 148 200 530
Respiratory mortality 0 7 11 15 50
Total non-accidental mortality 7 63 84 109 303
Air pollutants (in µgm−3)
NO2 1.3 5.8 9.8 14.0 38.3
NOx 1.7 7.6 13.3 19.8 74.7
PM2.5 3.2 5.6 6.1 6.5 9.1
PM10 5.5 9.0 10.0 10.8 13.9
remaining disease outcomes exhibit similar spatial patterns, with correlations107
ranging between 0.48 (between cardiovascular and respiratory mortality) and108
0.77 (between cardiovascular and total non-accidental mortality).109
2.2. Air pollution data110
The network of air pollution monitors and diffusion tubes is relatively111
sparse in Scotland (see http://www.scottishairquality.co.uk), and is112
not sufficient for the small-area scale of this study. Therefore in common113
with Haining et al. (2010) and Lee et al. (2009) we utilise modelled concen-114
trations instead, specifically annual averages for 2015 and 2016 from the Pol-115
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lution Climate Mapping (PCM) model (https://uk-air.defra.gov.uk/116
data/pcm-data) developed for the Department for the Environment, Food117
and Rural Affairs (DEFRA). This model estimates concentrations on a 1km118
square grid, which are spatially misaligned with the irregularly shaped Inter-119
mediate Zones that the disease data relate to. Such spatial misalignment is120
often addressed by simple averaging (see Haining et al., 2010), which is the121
approach adopted here. Specifically, each 1km grid square has an associated122
centroid (central point), and the estimated pollution concentration for an123
IZ is the mean of the grid square concentrations whose centroids lie within124
the IZ. Any IZ that does not contain a grid square centroid is assigned the125
pollution concentration from the nearest grid square.126
In this study we consider concentrations of nitrogen dioxide (NO2), nitro-127
gen oxides (NOx), and coarse (PM10) and fine (PM2.5) particulate matter, all128
of which are measured in µgm−3. These pollutants are chosen because they129
are the ones responsible for all but one of Scotland’s air quality management130
areas. The spatial distribution of PM2.5 is displayed in panel B of Figure131
2, which shows it is highest in the cities of Glasgow and Edinburgh as well132
as around the east and south east coasts, the latter due to transboundary133
pollution from continental Europe and England respectively.134
A summary of the spatial distributions of all 4 pollutants is displayed in135
Table 1, which shows that annual average concentrations are generally low.136
They also exhibit relatively little variation, with standard deviations of 5.5137
(NO2), 8.8 (NOx), 0.8 (PM2.5) and 1.4 (PM10) respectively. Thus presenting138
the estimated PM10-disease associations as relative risks for a 10µgm
−3 in-139
crease in concentrations, as is done in existing studies (see Dominici et al.,140
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2004), would not be sensible, because 10µgm−3 does not represent a plausi-141
ble increase given the data. Therefore in the results we specify relative risks142
based on a 5µgm−3 increase for NO2 and NOx, and a 1µgm−3 increase for143
PM2.5 and PM10, although we accept this is, as it has to be, a somewhat144
arbitrary choice. Finally, the four pollutants are highly correlated spatially,145
with correlations of: 0.99 between NOx and NO2; 0.98 between PM10 and146
PM2.5; and between 0.66 and 0.69 for all other pairs of pollutants.147
2.3. Confounder data148
One of the main factors affecting cardio-respiratory disease incidence is149
smoking (Hawthorne and Fry, 1978), and therefore areas with higher smok-150
ing prevalences are likely to exhibit higher numbers of disease incidents.151
However smoking prevalence data are unavailable at the IZ scale, but Klein-152
schmidt et al. (1995) have shown a strong link between smoking rates and153
socio-economic deprivation. Therefore we use the Scottish Index of Multi-154
ple Deprivation (SIMD, http://www.gov.scot/Topics/Statistics/SIMD)155
in our models as a proxy for smoking. The SIMD is a composite index con-156
sisting of deprivation indicators in the domains of access to services, crime,157
education, employment, health, housing and income, which are weighted and158
combined to create the final index.159
However, as the health domain in this overall index contains similar vari-160
ables to the disease outcome variables, it cannot be used as a covariate in161
the models. Therefore in the modelling described in Section 4 we consider162
the indicators for the 6 individual domains, excluding health, as possible co-163
variates. The crime indicator has a single IZ with a missing value, which is164
imputed by computing the average value from geographically neighbouring165
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Figure 2: Display of the data. The left panel (A) shows the standardised morbidity ratio
for respiratory hospitalisations, while the right panel (B) presents the average concentra-
tions of PM2.5.
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areas (those sharing a common border). Naturally however these six indi-166
cators are highly correlated, with the highest correlation being between the167
income and employment domains (correlation of 0.98). Finally, we also have168
the average number of dwellings per hectare, which is a proxy measure of169
property density and hence urbanicity.170
2.4. Assessment of residual spatial autocorrelation171
Here we examine whether the disease outcomes contain residual spatial172
autocorrelation after covariate adjustment, because this will affect the choice173
of model that is appropriate for these data. To assess the presence or ab-174
sence of such correlation, overdispersed quasi-Poisson log-linear models were175
fitted to each disease outcome separately, where the expected disease counts176
ek were included as an offset term. The covariates included in the models177
were selected from the set described in the previous section, where the se-178
lection was based on the significance (at the 5% level) of their association179
with the disease outcomes and their pairwise correlations. The residuals180
from these models contained substantial overdispersion, with the estimated181
overdispersion parameter ωˆ (where Var[Yk] = ωE[Yk]) ranging between 1.35182
and 6.41 across the 5 disease outcomes. The residuals also contained substan-183
tial spatial autocorrelation, which was assessed by performing permutation184
tests based on Moran’s I statistic (Moran, 1950). The Moran’s I statistics185
ranged between 0.04 and 0.38 and had p-values less than 0.01 in all cases,186
which suggests that spatially correlated random effects that also account for187
overdispersion should be included in the final model.188
However, the residual surfaces do not vary smoothly in space, and instead189
exhibit subregions of spatial smoothness separated by abrupt step changes.190
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This is illustrated in Section 1 of the supplementary material, which displays191
maps of the residuals from the model applied to the respiratory hospitalisa-192
tions data zoomed in to the cities of Glasgow and Edinburgh. The maps show193
that while most pairs of spatially neighbouring IZs exhibit similar residual194
values suggesting spatial autocorrelation, there are numerous examples of195
large step-changes between spatially neighbouring IZs. This suggests that a196
globally smooth spatial autocorrelation structure is unlikely to be appropri-197
ate for these data, which motivates the use of the localised spatial smoothing198
model described in the next section.199
3. Methodology200
We quantify the impact of air pollution on disease risk using the spa-201
tial hierarchical regression model proposed by Lee and Mitchell (2013), be-202
cause it allows for localised spatial autocorrelation that is present between203
some pairs of neighbouring areas but absent between other pairs. Infer-204
ence is undertaken in a Bayesian paradigm using Integrated Nested Laplace205
Approximations (INLAs, Rue et al., 2009), utilising the R package INLA206
(http://www.r-inla.org). The overall model is presented in Section 3.1,207
while the iterative estimation algorithm is presented in Section 3.2. The208
model is fitted separately for each disease outcome, because this ensures209
that the cross correlations between the disease outcomes do not affect the210
estimated pollution-health relationships.211
3.1. Overall model212
Recall that (Yk, ek) respectively denote the observed and expected num-213
bers of disease events in IZ k for k = 1, . . . , K, while xk denotes the concen-214
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tration of a single pollutant and zk = (1, zk1, . . . , zkp) denotes a vector of p215
confounders including an intercept term. The data likelihood model is given216
by217
Yk ∼ Poisson(ekθk) for k = 1, . . . , K (1)
ln(θk) = z
>
kα + xkβ + φk,
where θk is the risk of disease relative to ek and can be interpreted on218
the same scale as the SMR. The regression parameters corresponding to219
each confounder (α = (α1, . . . , αp)) and the air pollution covariate (β) are220
assigned independent weakly informative Gaussian prior distributions, with221
a mean of zero and a variance of 100,000. The remaining term in the linear222
predictor is a set of random effects φ = (φ1, . . . , φK), which account for the223
residual overdispersion and spatial autocorrelation in the disease data not224
captured by the covariates. The spatial structure of the K IZs is quantified225
by a non-negative symmetric K ×K neighbourhood matrix W, and here we226
use the common binary specification where wki = 1 if areas (k, i) share a227
common border (denoted k ∼ i) and wki = 0 otherwise (also wkk = 0 ∀k).228
Then based on W we model φ using the conditional autoregressive (CAR)229
prior proposed by Leroux et al. (2000):230
φk|φ−k,W, τ 2, ρ ∼ N
(
ρ
∑K
i=1wkiφi
ρ
∑K
i=1wki + 1− ρ
,
τ 2
ρ
∑K
i=1wki + 1− ρ
)
(2)
τ 2 ∼ Inverse-gamma(1, 0.01)
ρ ∼ Uniform(0, 1),
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where φ−k denotes the vector of random effects except φk. The prior mean231
of φk is a weighted average of the random effects φi in neighbouring areas232
(those for which wki = 1), which thus induces spatial autocorrelation into φ.233
The strength of this spatial autocorrelation is controlled by ρ, where ρ = 1234
corresponds to strong spatial autocorrelation and simplifies to the intrinsic235
CAR model of Besag et al. (1991), while ρ = 0 corresponds to independence236
(φk ∼ N(0, τ 2)). However, model (2) enforces the random effects to exhibit237
a single global level of spatial smoothness controlled by ρ, which can be seen238
from its implied partial autocorrelations:239
Corr[φk, φi|φ−ki] =
ρwki√
(ρ
∑K
j=1wkj + 1− ρ)(ρ
∑K
j=1wij + 1− ρ)
. (3)
Thus if ρ is close to one then all pairs of random effects in neighbouring240
areas where wki = 1 will be partially autocorrelated, whilst if ρ is zero then241
they will all be independent. However, the exploratory analysis showed that242
such global spatial smoothness is inappropriate for our data, because some243
pairs of neighbouring areas have very similar values, suggesting ρ should244
be close to one, whilst other neighbouring pairs have very different values,245
suggesting ρ should be close to zero.246
Therefore we take the approach of Lee and Mitchell (2013) and estimate247
each element in the set {wki|k ∼ i} as 0 or 1, rather than assuming it is fixed248
equal to 1. Equation (3) shows that if wki = 1 then (φk, φi) will be modelled249
as partially autocorrelated and hence smoothed over in the modelling, while250
if wki = 0 then (φk, φi) are modelled as conditionally independent and no251
such spatial smoothing is enforced. The major challenge when estimating252
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{wki|k ∼ i} is overparameterisation, because there are K = 1252 data points253
and 3281 neighbourhood elements {wki|k ∼ i} to be estimated. Therefore254
we update {wki|k ∼ i} deterministically based on the remaining model pa-255
rameters Θ = (α, β,φ, τ 2, ρ) in an iterative algorithm, rather than assigning256
each wki parameter a Bernoulli prior distribution. The algorithm proposed257
by Lee and Mitchell (2013) and used here is outlined below.258
3.2. Iterative estimation algorithm259
The algorithm iterates between updating: (i) Θ|W and (ii) W|Θ until260
convergence of W as follows.261
Estimation Algorithm262
1: Estimate a starting posterior distribution for Θ, by fitting model (1)-263
(2) based on the assumption that the random effects are independent264
(ρ = 0).265
2: Iterate the following two steps for j = 1, 2, . . . , j∗, until one of the two266
termination conditions for W outlined in step 3 are met.267
a: Estimate W(j) deterministically based on the current posterior dis-268
tribution f(Θ(j−1)|Y,W(j−1)), by setting w(j)ki = w(j)ik = 1 if the269
marginal 95% posterior credible intervals for (φ
(j−1)
k , φ
(j−1)
i ) over-270
lap and areas (k, i) share a common border. Otherwise, set w
(j)
ki =271
w
(j)
ik = 0.272
b: Estimate the posterior distribution f(Θ(j)|Y,W(j)) by fitting model273
(1)-(2) using INLA.274
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3: After j∗ iterations one of the following termination conditions will apply.275
Case 1 - The sequence of W estimates is such that W(j
∗) = W(j
∗+1),276
which is the estimated hyperparameter matrix Wˆ.277
Case 2 - The sequence of W estimates forms a cycle of m different278
states (W(j
∗),W(j
∗+1), . . . ,W(j
∗+m−1),W(j
∗+m)), where W(j
∗) =279
W(j
∗+m). In this case the estimated hyperparameter matrix Wˆ280
is the value from the cycle of m states that has the minimal level281
of residual spatial autocorrelation, as measured by the absolute282
value of Moran’s I statistic.283
When one of the termination conditions has been met Wˆ is the esti-284
mated spatial structure of the random effects, and Θ is summarised by285
the posterior distribution f(Θ|Y,Wˆ).286
The algorithm is initialized by assuming the random effects are indepen-287
dent so that initial spatial smoothness constraints are not imposed on the288
random effects. The update of W in step 2a assumes that if there is a sub-289
stantial difference between the current estimates of (φk, φi), that is their 95%290
credible intervals do not overlap, then they should be modelled as condition-291
ally independent, otherwise they are modelled as autocorrelated. In practice,292
the W estimates converge to a single value (Case 1) after a small number of293
iterations in almost all cases, and full details of the algorithm are given in294
Lee and Mitchell (2013).295
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4. Results296
This section presents the results of the study, including the model build-297
ing process, pollution-health relative risk estimates, and the impact of air298
pollution reductions on health.299
4.1. Model building300
We fit single disease and single pollutant models in this study, resulting301
in 20 different disease-pollutant combinations. Single disease models ensure302
that any cross correlations between the disease outcomes do not affect the303
estimated pollution-health relationships, while single pollutant models are304
used because of the high collinearity between the four pollutants (pairwise305
correlations range between 0.66 and 0.99) which hinders reliable joint estima-306
tion. To assess the robustness of our results to model choice we fit 2 different307
spatial autocorrelation models to the data, which are the Poisson log-linear308
Leroux CAR model ((1) and (2)), and the Poisson log-linear locally adaptive309
CAR model ((1) and (2) with the estimation of W as described in Section310
3.2).311
Each disease outcome is modelled by the expected numbers of disease312
events as an offset, one of the four pollutants, and a subset of the confounders313
outlined in Section 2, the latter including the dwellings per hectare variable314
and the 6 domain specific indicators of the SIMD. The main challenge with315
confounder selection is collinearity, because the education, employment and316
income domains all have high pairwise correlations above 0.86. Fitting mod-317
els with each of these variables separately shows that the income domain318
variable describes the most variation in the data, and thus is the one re-319
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tained with the other two being discarded. The remaining confounders do320
not exhibit this collinearity problem, and as they are all significantly related321
to most of the disease outcomes, they are retained in all models for con-322
sistency. Therefore, the set of confounders included in each model are the323
access to services, crime, housing and income domains of the SIMD, as well324
as the dwellings per hectare variable.325
The overall fits to the data of each model are presented in Table 2, which326
displays their Watanabe Akaike Information Criterion (WAIC, Watanabe,327
2010) value and the estimated effective number of independent parameters328
(p.w). The results presented relate to when PM2.5 was the pollutant included329
in the model, but the results for the other pollutants are almost identical and330
are not shown for brevity. The locally adaptive CAR model fits the two hos-331
pitalisation outcomes and total non-accidental mortality outcome better than332
the Leroux CAR model, with reductions in WAIC of 135 (cardiovascular),333
209 (respiratory) and 22 (mortality) respectively. These improvements in334
model fit are achieved despite the locally adaptive model having a smaller335
effective number of independent parameters than the Leroux model. This336
phenomenon occurs because the random effects from the Leroux CAR model337
are globally spatially smooth, which hence forces smoothness between the338
residual risks in geographically neighbouring IZs, even if the residual risks339
are very different. This inflates the random effects variance τ 2 because the340
residual risks are not spatially smooth, which results in a greater number of341
effective parameters. In contrast, the locally adaptive model does not smooth342
the residual risks in geographically adjacent IZs where those residual risks343
are very different, because it sets the corresponding wki = wik elements equal344
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Table 2: Watanabe-Akaike Information Criterion (WAIC) and the effective number of
independent parameters from the Leroux and Locally adaptive CAR models. For the
latter the number of {wki} elements estimated as zero is also presented.
Disease outcome Model WAIC p.w Number of {wki} set to zero
Cardiovascular hospitalisations Leroux 10,506 564 -
Adaptive 10,371 495 115 (3.5%)
Cardiovascular mortality Leroux 7,753 276 -
Adaptive 7,753 275 2 (0.1%)
Respiratory hospitalisations Leroux 10,706 616 -
Adaptive 10,497 522 386 (11.8%)
Respiratory mortality Leroux 6,874 244 -
Adaptive 6,871 251 0 (0%)
Total non-accidental mortality Leroux 9,782 528 -
Adaptive 9,760 489 150 (4.6%)
to zero and thus does not assume any partial autocorrelations between the345
random effects in those IZs.346
The largest number of {wki} elements estimated as zero is 386 (11.8%)347
for respiratory hospitalisations, while 115 (3.5%) and 150 (4.6%) were set348
to zero for cardiovascular hospitalisations and total non-accidental mortality349
respectively. In contrast, the two CAR models exhibit the same overall fit for350
the other two disease outcomes, which occurs because the locally adaptive351
model hardly estimates any wki = 0 and hence it simplifies to the Leroux352
CAR model.353
4.2. Pollution-health effects354
The effects of each pollutant on each disease outcome estimated from355
the locally adaptive CAR model are presented in Table 3, while the corre-356
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sponding effects for the non-pollutant covariates are presented in Section 2357
of the supplementary material accompanying this paper. For completeness,358
the pollution-disease effects estimated from the model with the Leroux CAR359
prior are displayed in Section 3 of the supplementary material, and show360
little change to those presented here, suggesting our results are robust to the361
choice of spatial autocorrelation model. Table 3 displays relative risks and362
95% credible intervals for a 5µgm−3 increase in NO2 and NOx and a 1µgm−3363
increase in PM2.5 and PM10, because as discussed in Section 2.2, these are364
realistic increases for each of the pollutants.365
Table 3 shows that in this study air pollution only has a significant asso-366
ciation with respiratory disease. This is shown prominently for respiratory367
hospitalisations, where all four pollutants exhibit significant associations. For368
respiratory mortality the estimated associations are largely similar in size,369
and the lack of significance at the traditional 5% level (except for PM2.5)370
is because of the much wider credible intervals for this disease outcome, re-371
sulting from the much lower numbers of disease counts (less data) compared372
with respiratory hospitalisations. The effect sizes for respiratory hospitalisa-373
tions range between a 1.4% and a 5.8% increased risk for the given pollutant374
increases, although given the differing levels of spatial variation in the pol-375
lutants these risks are not directly comparable. Cardiovascular disease and376
total non-accidental mortality appear to have no relationship with any of the377
four pollutants, because all 12 of the 95% credible intervals contain the null378
risk of one, and the estimated risks are mostly very close to one.379
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Table 3: Estimated relative risks and 95% credible intervals for the pollution-disease effects
from the model with the Locally adaptive CAR prior. The results for NO2 and NOx relate
to a 5µgm−3 increase whilst those for PM2.5 and PM10 relate to a 1µgm−3 increase. The
significant associations are shown in bold.
Disease outcome
Pollutant
NO2 NOx PM2.5 PM10
Cardiovascular hospitalisations 1.012 1.006 1.018 1.006
(0.994, 1.030) (0.995, 1.016) (0.997, 1.040) (0.995, 1.017)
Cardiovascular mortality 0.988 0.993 0.995 0.997
(0.970, 1.006) (0.982, 1.005) (0.994, 1.016) (0.987, 1.008)
Respiratory hospitalisations 1.028 1.014 1.058 1.023
(1.008, 1.048) (1.002, 1.025) (1.034, 1.083) (1.011, 1.035)
Respiratory mortality 1.032 1.017 1.045 1.014
(0.997, 1.067) (0.996, 1.038) (1.002, 1.090) (0.992, 1.035)
Total non-accidental mortality 1.003 1.001 1.012 1.005
(0.986, 1.020) (0.990, 1.011) (0.992, 1.033) (0.995, 1.016)
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4.3. Estimating the health impact of pollution reductions380
We now use the modelling results to quantify the health impact of re-381
ducing air pollution concentrations in each IZ within the four main Scottish382
cities, Aberdeen, Dundee, Edinburgh and Glasgow, which will illustrate the383
potential health impact of the planned LEZs. We do this by computing the384
expected reduction in the numbers of disease cases (hospital admissions or385
mortalities) in each IZ over 2015-2016 if average concentrations over that386
two-year period had reduced by ωµgm−3. We undertake this analysis for387
each pollutant and disease outcome separately because we have implemented388
single pollutant and single disease models, and note that these estimated389
reductions should not be summed over pollutants or diseases as they are not390
independent. From equation (1) the estimated reduction in the expected391
number of disease events for the kth IZ, E[Yk], if pollutant xk reduced by392
ωµgm−3 is given by:393
Reductionk = E[Yk|xk]− E[Yk|xk − ω] (4)
= ek exp(z
>
k αˆ + xkβˆ + φˆk)− ek exp(z>k αˆ + (xk − ω)βˆ + φˆk)
= ek exp(z
>
k αˆ + xkβˆ + φˆk)[1− exp(−ωβˆ)]
= ekθˆk[1− exp(−ωβˆ)].
This reduction depends on the estimated air pollution and health effect394
βˆ, the pollution reduction ωµgm−3, the underlying size and demographics395
of the population at risk via ek, and the estimated level of disease risk via396
θˆk = exp(z
>
k αˆ + xkβˆ + φˆk). To understand the range of reductions that397
might be observed, Table 4 displays the estimated total reductions across398
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the four cities resulting from the following pollutant reductions: NO2 / NOx399
- 2µgm−3, 5µgm−3 and 10µgm−3; and PM2.5 / PM10 - 0.5µgm−3, 1µgm−3400
and 3µgm−3. Here each city is defined by its local authority region, and401
the pollution-disease combinations listed in the table relate to the significant402
associations from Table 3.403
The table shows that the estimated reductions in disease cases scales404
roughly linearly with the chosen pollution reductions, as for example increas-405
ing the reduction of PM2.5 from 0.5µgm
−3 to 1µgm−3 in Edinburgh results406
in around 400 and 800 fewer respiratory hospitalisations respectively. The407
biggest reductions are in Glasgow because it has the largest population in408
Scotland, with an estimated reduction of 1,576 fewer admissions to hospital409
over the two year study period (an average of 788 per year) due to respira-410
tory disease if PM2.5 reduced by 1µgm
−3. In contrast, Dundee, the smallest411
of the four cities, had an estimated reduction in admissions of 352 over the412
two-year period (on average 176 per year) for the same 1µgm−3 decrease in413
concentrations. Finally, as mortalities are much rarer than hospital admis-414
sions, the estimated reductions in respiratory mortalities are much smaller415
than the corresponding reductions for respiratory hospitalisations.416
Equation (4) shows that the health impact of a fixed ωµgm−3 reduction417
in a pollutant will vary by IZ, and thus where those reductions are highest418
would be where pollution reduction policies, such as an LEZ, would have the419
largest public health benefit. The left column of Figure 3 illustrates this, by420
displaying, for Edinburgh (top left) and Glasgow (top right), the estimated421
reductions in respiratory hospitalisations in each IZ between 2015-2016 that422
would have occurred if NO2 concentrations had been reduced by 5µgm
−3.423
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Table 4: Estimated reductions in the expected numbers of disease events in 2015-2016 in
Aberdeen, Dundee, Edinburgh and Glasgow if a pollutant decreased by ωµgm−3. The
values in brackets relate to the region containing the Glasgow LEZ.
Disease / Pollutant
City
Aberdeen Dundee Edinburgh Glasgow (LEZ)
Respiratory hospitalisations
NO2 - ω = 2 71 71 161 316 (5)
NO2 - ω = 5 176 175 398 784 (13)
NO2 - ω = 10 347 345 785 1547 (26)
NOx - ω = 2 35 35 80 158 (3)
NOx - ω = 5 88 88 199 393 (7)
NOx - ω = 10 175 175 395 781 (14)
PM2.5 - ω = 0.5 179 178 405 799 (14)
PM2.5 - ω = 1 354 352 798 1,576 (27)
PM2.5 - ω = 3 1005 999 2265 4474 (77)
PM10 - ω = 0.5 73 73 165 325 (6)
PM10 - ω = 1 144 143 325 641 (11)
PM10 - ω = 3 409 406 923 1820 (31)
Respiratory mortality
PM2.5 - ω = 0.5 12 10 22 39 (1)
PM2.5 - ω = 1 23 19 44 78 (1)
PM2.5 - ω = 3 66 55 126 224 (3)
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The right column of the figure presents the estimated NO2 concentrations424
for the two cities, allowing us to spatially compare the locations with the425
highest concentrations and the highest health impacts of reducing concen-426
trations. We have chosen to display the results for NO2 because traffic related427
interventions, such as the Glasgow LEZ, are designed to reduce this pollutant428
more than particulates. However, the same general pattern is observed for429
all 4 pollutants.430
The figure shows the same fundamental message for both cities, namely431
that reducing NO2 concentrations in a city centre where concentrations are432
highest and hence where LEZs are typically located, will likely have a rel-433
atively low public health impact. This is because city centres have com-434
paratively low resident populations at risk due to being mainly commercial435
centres, resulting in smaller estimated reductions in the numbers of disease436
events. The same observation is true for Aberdeen and Dundee, and the437
results are displayed in Section 4 of the supplementary material.438
The location for the Glasgow LEZ is highlighted by the blue line in Fig-439
ure 3, and the bottom right panel shows it has some of the highest NO2440
concentrations in the city. However, the bottom left panel shows that the441
health impact from reducing the concentrations in the LEZ will likely be442
small, as the three IZs that make up the LEZ combined have a total reduc-443
tion of 13 hospital admissions over 2015-2016 (on average between 6 and 7 a444
year), less than 2% of the estimated reduction for the whole city. The cor-445
responding reductions in estimated disease events for the LEZ for the other446
pollutants, health outcomes, and sizes of pollutant reduction are shown in447
brackets in Table 4, and again show very small numbers compared with the448
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city of Glasgow as a whole.449
5. Comparability of epidemiological air pollution studies450
Large numbers of epidemiological air pollution studies have been con-451
ducted across the world, which has led researchers and policy-makers to452
directly compare the results from multiple studies. However this is prob-453
lematic, because the estimated effect sizes will depend on both the strength454
of the pollution-health association and the amount of variation in pollution455
concentrations across the study region. To see this note that from equation456
(1) the risk for area k is given by457
θˆk = exp(z
>
k αˆ + xkβˆ + φˆk), (5)
where the exposure xk has mean x¯ =
1
K
∑K
k=1 xk and variance σ
2
x =458
1
n−1
∑K
k=1(xk− x¯)2. Now consider a linearly scaled exposure vk = (1+ψ)xk−459
ψx¯, where it is straightforward to show that they have the same mean (i.e.460
v¯ = x¯) and the variances are related by σ2v = (ψ + 1)
2σ2x. Then replacing xk461
by vk in equation (1) yields:462
θˆk = exp(z
>
k αˆ
∗ + vkβˆ∗ + φˆ∗k) (6)
= exp(z>k αˆ∗ + [(1 + ψ)xk − ψx¯]βˆ∗ + φˆ∗k)
= exp(z>k αˆ∗ + xk(1 + ψ)βˆ∗ − ψx¯βˆ∗ + φˆ∗k).
Comparing (5) and (6) shows that the coefficients for the scaled and463
unscaled exposures (vk, xk) are related by βˆ∗ =
βˆ
1+ψ
. Therefore, compar-464
ing estimated effect sizes between studies with different levels of exposure465
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Figure 3: Maps of the estimated reductions in respiratory hospitalisations in each IZ due
to a 5µgm−3 reduction in NO2 concentrations (left), and the average NO2 concentrations
(right). The top row refers to Edinburgh and the bottom row refers to Glasgow. The blue
line denotes the boundary of the proposed Glasgow LEZ.
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variation is not appropriate, because the level of exposure variation affects466
the estimated regression coefficient. This explains the large estimated effect467
sizes for PM2.5 on respiratory disease outcomes observed in this study, be-468
cause the level of variation in PM2.5 concentrations across Scotland is very469
low (the standard deviation in the two-year annual average concentrations is470
only 0.81µgm−3).471
6. Discussion472
This paper has presented a new study of the health impact of long-term473
exposure to air pollution in Scotland using a spatial small-area design, and474
has used the results to quantify the likely health impact of air pollution re-475
duction interventions such as Low Emission Zones. Our first main finding is476
that the four pollutants considered here exhibit associations with respiratory477
disease (hospitalisations and mortality), even though for mortality three of478
the relative risks are not significant at the 5% level as a result of small num-479
bers of deaths leading to wide credible intervals. In contrast, no associations480
were observed for cardiovascular disease or total non-accidental mortality,481
with all relative risks being non-significant and close to one in magnitude482
(ranging between 0.988 and 1.018). No significant associations between car-483
diovascular disease and air pollution were also found by Willocks et al. (2012)484
in Scotland and Dehbi et al. (2017) in Great Britain using time series and485
cohort methodologies respectively, which means our findings are consistent486
with previous studies on British populations.487
Our second main finding is that focusing an air pollution reduction inter-488
vention, such as an LEZ, on a city centre where concentrations are highest489
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is likely to have a relatively small positive health impact, because these ar-490
eas are largely commercial and hence have small resident populations. Even491
though these areas will routinely see large numbers of people visiting for both492
shopping and working, their time spent in the area, especially outdoors, will493
be relatively short. This suggests that this time will contribute only a small494
proportion to their total pollution exposure. The evidence presented here495
therefore suggests that the LEZ planned for Glasgow may have a relatively496
small positive net health benefit. We note however that our study has not497
evaluated the effect of the Glasgow LEZ directly, because the pollution re-498
ductions from the LEZ are not known as it will not be fully operational until499
the end of 2022. However, other studies have directly evaluated the impact500
of LEZs across Europe, including studies in Amsterdam (Panteliadis et al.,501
2014) and Munich (Fensterer et al., 2014) where the LEZ appeared to reduce502
concentrations, and in the UK (London and Birmingham, Jones et al., 2012)503
where it did not appear to reduce concentrations. A thorough review of LEZs504
is beyond the scope of this paper, and the reader is referred to Holman et al.505
(2015).506
The choice of where one should locate an air pollution intervention, such507
as an LEZ, depends on the ultimate goal. If the main aim is intended to508
be reducing the preventable adverse health impacts of air pollution, then509
Figure 3 suggests that an intervention should be targeted at areas that have510
both relatively high pollutant concentrations and a relatively large and more511
vulnerable population. In contrast, if compliance with air quality limits is the512
key requirement, such as reducing pollution concentrations below European513
Union limits (European Parliament, 2008), then interventions need only be514
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targeted at areas with the highest concentrations that are not in compliance.515
The main limitation of our work (shared by all other epidemiological air516
pollution studies) in respect of attempting to predict the potential health im-517
pacts of LEZs is the use of ambient residential concentrations as a proxy for518
personal exposures, which ignores peoples movements such as daily commut-519
ing patterns. In future work we will combine the methodology developed here520
with population movement models, to identify the possible health impacts521
of reducing air pollution in city centres on personal exposures. Additionally,522
we will consider the impact of an LEZ on air pollution concentrations in the523
rest of the city, which are likely to occur because an LEZ will require cleaner524
buses that will service routes that travel out-with the LEZ area.525
A second limitation with this study is that the pollution data are assumed526
to be true and measured without error, where as in fact they come from the527
atmospheric PCM model and thus are subject to error and uncertainty. Nu-528
merous solutions have been proposed to allow for pollution uncertainty in529
disease models, and a recent example using fusion modelling (Berrocal et al.,530
2010) is provided by Blangiardo et al. (2016). A further limitation is the531
ecological nature of this small-area study, which in common with time series532
studies (e.g. Dominici et al., 2004), uses population-level disease summaries533
rather than individual-level data. This means that only group level associ-534
ations rather than individual-level cause and effect can be estimated, which535
provides a weaker evidence base. However, individual-level disease data are536
not available for confidentiality purposes, and population-level small-area537
studies are commonplace and are critiqued by Wakefield (2007).538
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